A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.
Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.
A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.
Proteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands.
The reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule which contained damaged regions. The major repair mechanisms are excision repair, in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand; photoreactivation repair, in which the lethal and mutagenic effects of ultraviolet light are eliminated; and post-replication repair, in which the primary lesions are not repaired, but the gaps in one daughter duplex are filled in by incorporation of portions of the other (undamaged) daughter duplex. Excision repair and post-replication repair are sometimes referred to as "dark repair" because they do not require light.
Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.
A characteristic symptom complex.
A general transcription factor that is involved in basal GENETIC TRANSCRIPTION and NUCLEOTIDE EXCISION REPAIR. It consists of nine subunits including ATP-DEPENDENT DNA HELICASES; CYCLIN H; and XERODERMA PIGMENTOSUM GROUP D PROTEIN.
Recession of the eyeball into the orbit.
A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
A DNA helicase that is a component of TRANSCRIPTION FACTOR TFIIH. It plays an essential role in NUCLEOTIDE EXCISION REPAIR, and mutations in this protein are associated with XERODERMA PIGMENTOSUM.
Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.
Changes in the organism associated with senescence, occurring at an accelerated rate.
Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-.
An orphan nuclear receptor that has specificity for hormone response elements found in the promoters of target genes. It binds DNA either as a homodimer or as heterodimer with the closely-related orphan nuclear receptor NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1. The protein was originally identified as a TESTES-specific protein and is involved in the regulation of variety of cellular processes, including CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.
Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.
Proteins produced from GENES that have mutated by the fusing of protein coding regions of more than one gene. Such hybrid proteins are responsible for some instances of ANTIBIOTIC RESISTANCE and defective biological processes such as NEOPLASMS.
A ZINC FINGER MOTIF protein that recognizes and interacts with damaged DNA. It is a DNA-binding protein that plays an essential role in NUCLEOTIDE EXCISION REPAIR. Mutations in this protein are associated with the most severe form of XERODERMA PIGMENTOSUM.
Autosomal recessive neuroectodermal disorders characterized by brittle sulfur-deficient hair associated with impaired intellect, decreased fertility, and short stature. It may include nail dystrophy, ICHTHYOSIS, and photosensitivity correlated with a NUCLEOTIDE EXCISION REPAIR defect. All individuals with this disorder have a deficiency of cysteine-rich KERATIN-ASSOCIATED PROTEINS found in the interfilamentous matrix. Photosensitive trichothiodystrophy can be caused by mutation in at least 2 separate genes: ERCC2 PROTEIN gene and the related ERCC3. Nonphotosensitive trichothiodystrophy can be caused by mutation in the TTDN1 gene.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
The so-called general transcription factors that bind to RNA POLYMERASE II and that are required to initiate transcription. They include TFIIA; TFIIB; TFIID; TFIIE; TFIIF; TFIIH; TFII-I; and TFIIJ. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.
Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.
Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION.
The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
Established cell cultures that have the potential to propagate indefinitely.
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)

Base excision repair of oxidative DNA damage activated by XPG protein. (1/194)

Oxidized pyrimidines in DNA are removed by a distinct base excision repair pathway initiated by the DNA glycosylase--AP lyase hNth1 in human cells. We have reconstituted this single-residue replacement pathway with recombinant proteins, including the AP endonuclease HAP1/APE, DNA polymerase beta, and DNA ligase III-XRCC1 heterodimer. With these proteins, the nucleotide excision repair enzyme XPG serves as a cofactor for the efficient function of hNth1. XPG protein promotes binding of hNth1 to damaged DNA. The stimulation of hNth1 activity is retained in XPG catalytic site mutants inactive in nucleotide excision repair. The data support the model that development of Cockayne syndrome in XP-G patients is related to inefficient excision of endogenous oxidative DNA damage.  (+info)

Alterations in the CSB gene in three Italian patients with the severe form of Cockayne syndrome (CS) but without clinical photosensitivity. (2/194)

Cockayne syndrome (CS) is a rare autosomal recessive disorder characterized by postnatal growth failure, mental retardation and otherwise clinically heterogeneous features which commonly include cutaneous photosensitivity. Cultured cells from sun-sensitive CS patients are hypersensitive to ultraviolet (UV) light and, following UV irradiation, are unable to restore RNA synthesis rates to normal levels. This has been attributed to a specific deficiency in CS cells in the ability to carry out preferential repair of damage in actively transcribed regions of DNA. We report here a cellular and molecular analysis of three Italian CS patients who were of particular interest because none of them was sun-sensitive, despite showing most of the features of the severe form of CS, including the characteristic cellular sensitivity to UV irradiation. They all were altered in the CSB gene. The genetically related patients CS1PV and CS3PV were homozygous for the C1436T transition resulting in the change Arg453opal. Patient CS2PV was a compound heterozygote for two new causative mutations, insertions of an A at position 1051 and of TGTC at 2053, leading to truncated proteins of 367 and 681 amino acids. These mutations result in severely truncated proteins, as do many of those that we previously identified in several sun-sensitive CS-B patients. These observations confirm that the CSB gene is not essential for viability and cell proliferation, an important issue to be considered in any speculation on the recently proposed additional function of the CSB protein in transcription. Our investigations provide data supporting the notion that other factors, besides the site of the mutation, influence the type and severity of the CS clinical features.  (+info)

The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes. (3/194)

The human XPB DNA helicase is a subunit of the DNA repair/basal transcription factor TFIIH, involved in early steps of the nucleotide excision repair pathway. Two distinct clinical phenotypes, xeroderma pigmentosum associated with Cockayne's syndrome (XP/CS) and trichothiodystrophy (TTD), can be due to mutations in the XPB gene. In the present work, we studied cellular DNA repair properties of skin fibro-blasts from two patients mutated in the XPB gene: an XP/CS patient cell (XPCS2BA) with a T296C (F99S) transition and a TTD patient cell (TTD6VI) exhibiting an A355C (T119P) transversion. Both cells are clearly associated with different levels of alterations in their response to UV light. To establish the relationship between the relative expression level of these two alleles and DNA repair properties, we transfected SV40-transformed XPCS2BA (XPCS2BASV) cells with a plasmid (pTTD6VI) carrying the XPB-A355C cDNA and examined DNA repair properties after UV irradiation (cell survival, unscheduled DNA synthesis and kinetics of photoproduct removal) in stable transfectants. We isolated three clones, which express the XPB-A355C gene (Cl-5) or the XPB-T296C gene (Cl-14) or both genes (Cl-19). This con-stitutes a model system allowing us to correlate the relative expression levels of the XPB-A355C (TTD) and XPB-T296C (XP/CS) genes with various DNA repair properties. Overexpression of the XPB-A355C (TTD) gene in an XP/CS cell gives rise to a cellular phenotype of increased repair similar to that of TTD6VI cells, while equal expression of the two mutated genes leads to an intermediate cellular phenotype between XP/CS and TTD.  (+info)

Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription. (4/194)

Xeroderma pigmentosum (XP) is a rare hereditary human disorder clinically associated with severe sun sensitivity and predisposition to skin cancer. Some XP patients also show clinical characteristics of Cockayne syndrome (CS), a disorder associated with defective preferential repair of DNA lesions in transcriptionally active genes. Cells from the two XP-patients who belong to complementation group D and exhibit additional clinical symptoms of CS are strikingly more sensitive to the cytotoxic effects of UV-light than cells from classical XP-D patients. To explain the severe UV-sensitivity it was suggested that XP-D-CS cells have a defect in preferential repair of UV-induced 6-4 photoproducts (6-4PP) in active genes. We investigated the capacity of XP-D and XP-D-CS cells to repair UV-induced DNA lesions in the active adenosine deaminase gene (ADA) and in the inactive 754 gene by determining (i) the removal of specific lesions, i.e. cyclobutane pyrimidine dimers (CPD) and 6-4PP, or (ii) the formation of BrdUrd-labeled repair patches. No differences in repair capacity were observed between XP-D and XP-D-CS cells. In both cell types repair of CPD was completely absent whereas 6-4PP were inefficiently removed from the ADA gene and the 754 gene with similar kinetics. However, whereas XP-D cells were able to restore UV-inhibited RNA synthesis after a UV-dose of 2 J/m2, RNA synthesis in XP-D-CS cells remained repressed up to 24 h after irradiation. Our results are inconsistent with the hypothesis that differences in the capacity to perform preferential repair of UV-induced photolesions in active genes between XP-D and XP-D-CS cells are the cause of the extreme UV-sensitivity of XP-D-CS cells. Rather, the enhanced sensitivity of XP-D-CS cells may be associated with a defect in transcription regulation superimposed on the repair defect.  (+info)

Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition. (5/194)

Patients with the nucleotide excision repair (NER) disorder xeroderma pigmentosum (XP) are highly predisposed to develop sunlight-induced skin cancer, in remarkable contrast to photosensitive NER-deficient trichothiodystrophy (TTD) patients carrying mutations in the same XPD gene. XPD encodes a helicase subunit of the dually functional DNA repair/basal transcription complex TFIIH. The pleiotropic disease phenotype is hypothesized to be, in part, derived from a repair defect causing UV sensitivity and, in part, from a subtle, viable basal transcription deficiency accounting for the cutaneous, developmental, and the typical brittle hair features of TTD. To understand the relationship between deficient NER and tumor susceptibility, we used a mouse model for TTD that mimics an XPD point mutation of a TTD patient in the mouse germline. Like the fibroblasts from the patient, mouse cells exhibit a partial NER defect, evident from the reduced UV-induced DNA repair synthesis (residual repair capacity approximately 25%), limited recovery of RNA synthesis after UV exposure, and a relatively mild hypersensitivity to cell killing by UV or 7,12-dimethylbenz[a]anthracene. In accordance with the cellular studies, TTD mice exhibit a modestly increased sensitivity to UV-induced inflammation and hyperplasia of the skin. In striking contrast to the human syndrome, TTD mice manifest a dear susceptibility to UV- and 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis, albeit not as pronounced as the totally NER-deficient XPA mice. These findings open up the possibility that TTD is associated with a so far unnoticed cancer predisposition and support the notion that a NER deficiency enhances cancer susceptibility. These findings have important implications for the etiology of the human disorder and for the impact of NER on carcinogenesis.  (+info)

Potential roles for p53 in nucleotide excision repair. (6/194)

Ultraviolet (UV) light-induced DNA damage is repaired by the nucleotide excision repair pathway, which can be subdivided into transcription-coupled repair (TCR) and global genome repair (GGR). Treatment of cells with a priming dose of UV light appears to stimulate both GGR and TCR, suggesting that these processes are inducible. GGR appears to be disrupted in p53-deficient fibroblasts, whereas the effect of p53 disruption on TCR remains somewhat controversial. Normal recovery of mRNA synthesis following UV irradiation is thought to depend on TCR. We have found that the recovery of mRNA synthesis following exposure to UV light is severely attenuated in p53-deficient human fibroblasts. Therefore, p53 disruption may lead to a defect in TCR or a post-repair process required for the recovery of mRNA synthesis. Several different functions of p53 have been proposed which could contribute to these cellular processes. We suggest that p53 could participate in GGR and the recovery of mRNA synthesis following UV exposure through the regulation of steady-state levels of one or more p53-regulated gene products important for these processes. Furthermore, we suggest that the role of p53 in the recovery of mRNA synthesis is important for resistance to UV-induced apoptosis.  (+info)

The interpretation of optical coherence tomography images of the retina. (7/194)

PURPOSE: To determine the relationship between optical coherence tomography (OCT) images of the retina and retinal substructure in vitro and in vivo. METHODS: In vitro, OCT images of human and bovine retina were acquired after sequential excimer laser ablation of the inner retinal layers. Measurements of bands in the OCT images were compared with measurements of retinal layers on histology of the ablated specimens. In vivo, OCT images were acquired of retinal lesions in which there was a displacement of pigmented retinal pigment epithelial (RPE) cells: retinitis pigmentosa and laser photocoagulation (eight eyes each). RESULTS: The mean thickness of human inner OCT bands (131 microm; 95% confidence interval [CI], 122-140 microm) was 7.3 times that of the retinal nerve fiber layer (RNFL). This band persisted despite ablation greater than 140 microm. The inner aspect of the outer OCT band corresponded to the apical RPE, but the mean thickness of this band in human tissue (55 microm; 95% CI, 48-62 microm) was 2.6 times the thickness of the RPE-choriocapillaris complex. OCT measurement of total retinal thickness was accurate (coefficient of variance, 0.05) and precise (coefficient of correlation with light microscopy, 0.98). Hyperpigmented lesions gave rise to high signal, attenuating deeper signal; hypopigmented lesions had the opposite effect on deeper signal. CONCLUSIONS: The inner band is not RNFL specific, partly consisting of a surface-related signal. The location, not thickness, of the outer band corresponds to RPE melanin. Given the additional effect of polarization settings, precise OCT measurement of specific retinal layers is currently precluded.  (+info)

Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells. (8/194)

Proliferating cell nuclear antigen (PCNA), a processivity factor for DNA polymerases delta and epsilon, is essential for both DNA replication and repair. PCNA is required in the resynthesis step of nucleotide excision repair (NER). After UV irradiation, PCNA translocates into an insoluble protein complex, most likely associated with the nuclear matrix. It has not previously been investigated in vivo whether PCNA complex formation also takes place after oxidative stress. In this study, we have examined the involvement of PCNA in the repair of oxidative DNA damage. PCNA complex formation was studied in normal human cells after treatment with hydrogen peroxide, which generates a variety of oxidative DNA lesions. PCNA was detected by two assays, immunofluorescence and western blot analyses. We observed that PCNA redistributes from a soluble to a DNA-bound form during the repair of oxidative DNA damage. PCNA complex formation was analyzed in two human natural mutant cell lines defective in DNA repair: xeroderma pigmentosum group A (XP-A) and Cockayne syndrome group B (CS-B). XP-A cells are defective in overall genome NER while CS-B cells are defective only in the preferential repair of active genes. Immunofluorescent detection of PCNA complex formation was similar in normal and XP-A cells, but was reduced in CS-B cells. Consistent with this observation, western blot analysis in CS-B cells showed a reduction in the ratio of PCNA relocated as compared to normal and XP-A cells. The efficient PCNA complex formation observed in XP-A cells following oxidative damage suggests that formation of PCNA-dependent repair foci may not require the XPA gene product. The reduced PCNA complex formation observed in CS-B cells suggests that these cells are defective in the processing of oxidative DNA damage.  (+info)

The symptoms of Cockayne syndrome can vary in severity and may include:

* Severe developmental delays and intellectual disability
* Poor muscle tone and coordination
* Vision and hearing loss
* Short stature
* Small head size (microcephaly)
* Abnormalities of the face and skull
* Increased risk of infections and cancer

There is no cure for Cockayne syndrome, and treatment is focused on managing the symptoms and preventing complications. This may include:

* Physical therapy to improve muscle tone and coordination
* Speech and language therapy to improve communication skills
* Occupational therapy to develop daily living skills
* Medications to manage seizures, if present
* Regular monitoring by a multidisciplinary team of healthcare professionals

The prognosis for individuals with Cockayne syndrome is generally poor, and many do not survive beyond early childhood. However, with appropriate medical care and support, some individuals with this condition may live into their teenage years or even longer.

It's important to note that Cockayne syndrome is a rare disorder, and it can be challenging to diagnose and manage. A thorough evaluation by a team of healthcare professionals, including a geneticist, is necessary for accurate diagnosis and appropriate management.

The main symptoms of XP include:

1. Extremely sensitive skin that burns easily and develops freckles and age spots at an early age.
2. Premature aging of the skin, including wrinkling and thinning.
3. Increased risk of developing skin cancers, especially melanoma, which can be fatal if not treated early.
4. Poor wound healing and scarring.
5. Eye problems such as cataracts, glaucoma, and poor vision.
6. Neurological problems such as intellectual disability, seizures, and difficulty with coordination and balance.

XP is usually inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene, one from each parent, to develop the condition. The diagnosis of XP is based on clinical features, family history, and genetic testing. There is no cure for XP, but treatment options include:

1. Avoiding UV radiation by staying out of the sun, using protective clothing, and using sunscreens with high SPF.
2. Regular monitoring and early detection of skin cancers.
3. Chemoprevention with drugs that inhibit DNA replication.
4. Photoprotection with antioxidants and other compounds that protect against UV damage.
5. Managing neurological problems with medications and therapy.

The prognosis for XP is poor, with most patients dying from skin cancer or other complications before the age of 20. However, with early diagnosis and appropriate treatment, some patients may be able to survive into their 30s or 40s. There is currently no cure for XP, but research is ongoing to develop new treatments and improve the quality of life for affected individuals.

There are several types of photosensitivity disorders, including:

1. Photodermatitis: This is a common condition that causes skin redness, itching, and blisters after exposure to UV radiation. It can be triggered by medications, certain plants, or even some cosmetics.
2. Solar urticaria: This condition causes hives and other skin symptoms after exposure to sunlight. The triggers can include not only UV radiation but also heat, wind, or cold.
3. Photosensitive epilepsy: This is a rare condition that can cause seizures in individuals who have a history of epilepsy. Exposure to certain types of light, especially flickering lights or bright colors, can trigger seizures.
4. Chronic actinic dermatitis: This condition causes skin inflammation and sensitivity to UV radiation, leading to redness, itching, and burning. It is more common in older adults and those with fair skin.

The symptoms of photosensitivity disorders can vary depending on the type of condition and the individual. Common symptoms include:

* Skin redness and irritation
* Itching and burning sensations
* Blisters or hives
* Swelling and inflammation
* Eye irritation or vision problems
* Headaches or fatigue
* Seizures (in the case of photosensitive epilepsy)

Photosensitivity disorders can be caused by a variety of factors, including:

1. Genetic predisposition: Some individuals may be more susceptible to photosensitivity due to their genetic makeup.
2. Medications: Certain medications, such as antibiotics and antipsychotics, can cause photosensitivity as a side effect.
3. Plants or other environmental factors: Exposure to certain plants or other environmental triggers can cause photosensitivity in some individuals.
4. Medical conditions: Certain medical conditions, such as lupus or porphyria, can increase the risk of developing photosensitivity.

There is no cure for photosensitivity disorders, but there are several treatment options available to help manage symptoms and prevent complications. These may include:

1. Avoiding triggers: Individuals with photosensitive conditions should avoid exposure to triggers such as sunlight or certain chemicals.
2. Protective clothing and gear: Wearing protective clothing and gear, such as hats and long sleeves, can help prevent skin exposure to UV radiation.
3. Medications: Topical creams and ointments, oral medications, or injectable treatments may be prescribed to manage symptoms such as itching and inflammation.
4. Phototherapy: Exposure to specific wavelengths of light, such as UVB or PUVA, can help improve skin conditions in some individuals.
5. Lifestyle modifications: Avoiding triggers, protecting the skin, and managing underlying medical conditions can help reduce the risk of complications associated with photosensitivity disorders.

It is important to note that photosensitivity disorders can be unpredictable, and the severity of symptoms can vary from person to person and over time. If you suspect you or someone you know may have a photosensitivity disorder, it is essential to consult with a healthcare professional for proper diagnosis and treatment.

Examples of syndromes include:

1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.

Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.

Enophthalmos can cause a range of symptoms including:

* Diplopia (double vision)
* Blurred vision
* Eye strain and fatigue
* Headaches
* Difficulty moving the eyes
* Decreased vision in the affected eye

Enophthalmos is often diagnosed through a comprehensive eye exam, which includes a visual acuity test, refraction test, and imaging studies such as MRI or CT scans to rule out other conditions.

Treatment options for enophthalmos depend on the underlying cause of the condition. In some cases, glasses or contact lenses may be prescribed to correct refractive errors that contribute to the condition. Surgery may be necessary in more severe cases, such as when the condition is caused by a tumor or other structural abnormality. In other cases, prism lenses or eye muscle surgery may be recommended to help realign the eyes and improve vision.

Overall, enophthalmos is a rare and potentially vision-threatening condition that requires prompt medical attention from an eye care professional for proper diagnosis and treatment.

1. Medical Definition: In medicine, dwarfism is defined as a condition where an individual's height is significantly below the average range for their age and gender. The term "dwarfism" is often used interchangeably with "growth hormone deficiency," but the two conditions are not the same. Growth hormone deficiency is a specific cause of dwarfism, but there can be other causes as well, such as genetic mutations or chromosomal abnormalities.
2. Genetic Definition: From a genetic perspective, dwarfism can be defined as a condition caused by a genetic mutation or variation that results in short stature. There are many different genetic causes of dwarfism, including those caused by mutations in the growth hormone receptor gene, the insulin-like growth factor 1 (IGF1) gene, and other genes involved in growth and development.
3. Anthropological Definition: In anthropology, dwarfism is defined as a physical characteristic that is considered to be outside the normal range for a particular population or culture. This can include individuals who are short-statured due to various causes, including genetics, nutrition, or environmental factors.
4. Social Definition: From a social perspective, dwarfism can be defined as a condition that is perceived to be different or abnormal by society. Individuals with dwarfism may face social stigma, discrimination, and other forms of prejudice due to their physical appearance.
5. Legal Definition: In some jurisdictions, dwarfism may be defined as a disability or a medical condition that is protected by anti-discrimination laws. This can provide legal protections for individuals with dwarfism and ensure that they have access to the same rights and opportunities as others.

In summary, the definition of dwarfism can vary depending on the context in which it is used, and it may be defined differently by different disciplines and communities. It is important to recognize and respect the diversity of individuals with dwarfism and to provide support and accommodations as needed to ensure their well-being and inclusion in society.

There are several types of premature aging, including:

1. Progeria: This is a rare genetic condition that causes accelerated aging in children, resulting in a shortened life span.
2. Hutchinson-Gilford progeria syndrome: This is the most common form of progeria, which affects approximately 1 in 4 million children worldwide. Children with this condition typically die before reaching their teenage years due to complications such as heart attack or stroke.
3. Wiedemann-Steiner syndrome: This is a rare genetic disorder that causes premature aging, including wrinkled skin, thinning hair, and joint stiffness.
4. Werner syndrome: This is a rare genetic disorder that affects approximately 1 in 250,000 individuals worldwide. It is characterized by premature aging, including grey hair, wrinkled skin, and a high risk of developing cancer and other age-related diseases.
5. Telomere shortening: Telomeres are the protective caps at the end of chromosomes that shorten with each cell division. Premature telomere shortening can lead to accelerated aging and an increased risk of age-related diseases.
6. Chronic stress: Prolonged exposure to chronic stress can lead to premature aging, including changes in the brain, skin, and immune system.
7. Poor nutrition: A diet lacking essential nutrients can lead to premature aging, including vitamin D deficiency, which is associated with an increased risk of osteoporosis and other age-related diseases.
8. Lack of exercise: Physical inactivity can contribute to premature aging, including decreased muscle mass, bone density, and cognitive function.
9. Smoking: Cigarette smoking is a significant risk factor for premature aging, including wrinkles, age spots, and an increased risk of cancer and cardiovascular disease.
10. Alcohol consumption: Excessive alcohol consumption can lead to premature aging, including liver damage, heart disease, and certain types of cancer.

While many of these factors are beyond our control, there are steps we can take to reduce their impact and promote healthy aging. These include maintaining a balanced diet, exercising regularly, getting enough sleep, managing stress, not smoking, and limiting alcohol consumption. Additionally, staying up-to-date on preventative healthcare measures, such as regular check-ups and screenings, can help identify and address any potential health issues before they become more serious.

1. Epidermolysis bullosa (EB): A group of rare genetic disorders that affect the skin and mucous membranes, causing blisters and sores to form easily.
2. Ichthyosis: A group of genetic disorders that cause dry, thickened skin and scales to form.
3. Netherton syndrome: A rare genetic disorder that causes a combination of skin symptoms, including thinning of the skin, increased risk of infections, and difficulty healing wounds.
4. Pyoderma gangrenosum: A rare genetic disorder that causes painful, ulcerating sores on the skin.
5. X-linked dystonia-Episodes Myoclonus (XLDE): A rare genetic disorder that causes muscle spasms and movement problems, as well as skin symptoms such as thickened skin and difficulty swallowing.
6. Neurofibromatosis type 1: A genetic disorder that causes tumors to grow on nerve tissue, which can also affect the skin and cause symptoms such as freckling and skin thickening.
7. Tuberous sclerosis complex (TSC): A rare genetic disorder that causes non-cancerous growths (tumors) to form in organs such as the brain, heart, kidneys, and skin.
8. Vitiligo: An autoimmune disorder that causes the loss of pigment-producing cells (melanocytes) in the skin, leading to white patches.
9. Alopecia areata: An autoimmune disorder that causes hair loss, often starting with small patches on the scalp or face.

These are just a few examples of genetic skin diseases, and there are many more that can affect the skin in different ways. Treatment for these conditions varies depending on the specific diagnosis and severity of symptoms, but may include medications, lifestyle changes, or surgery to remove growths or improve appearance.

The term "trichothiodystrophy" was coined in the 1980s to describe a group of patients with similar clinical features, including trichodystrophic hair, cognitive impairment, and various other physical anomalies. Since then, several forms of TTD have been identified, each with distinct clinical features and genetic causes.

The most common forms of TTD include:

1. Trichothiodystrophy type 1 (also known as "classic" TTD): This is the most common form of TTD, accounting for about 70% of all cases. It is caused by mutations in the helicase-like protein 48 (HLF) gene, which plays a critical role in DNA repair and replication.
2. Trichothiodystrophy type 2 (TTD2): This form of TTD is caused by mutations in the gene encoding the enzyme p53-regulated protein (PRPS1). PRPS1 is involved in the regulation of protein synthesis and folding, and mutations in this gene can lead to a variety of developmental defects.
3. Trichothiodystrophy type 3 (TTD3): This form of TTD is caused by mutations in the gene encoding the enzyme mitochondrial DNA polymerase gamma (POLG). POLG is involved in the replication and repair of mitochondrial DNA, which is essential for the proper functioning of mitochondria.

Other forms of TTD include X-linked trichothiodystrophy (XLID), which affects males almost exclusively and is caused by mutations in the gene encoding the enzyme ornithine transcarbamylase (OTC); and trichothiodystrophy type 4 (TTD4), which is caused by mutations in the gene encoding the enzyme thymine dimer-specific photolyase (TDP1).

Trichothiodystrophy can have a wide range of symptoms, depending on the specific form of the disorder. These may include:

* Developmental delays and intellectual disability
* Skeletal abnormalities, such as short stature, scoliosis, and joint deformities
* Skin changes, such as photosensitivity, thinning of the skin, and pigmentary changes
* Vision problems, including cataracts, glaucoma, and progressive retinal degeneration
* Hearing loss
* Neurological problems, such as seizures, tremors, and ataxia (loss of coordination)
* Mitochondrial myopathy, which is a muscle disorder that can cause weakness, muscle wasting, and muscle cramps.

There is no cure for trichothiodystrophy, but treatment options are available to manage the symptoms. These may include:

* Medications to control seizures and other neurological problems
* Physical therapy to improve muscle strength and coordination
* Occupational therapy to improve daily functioning
* Speech therapy to improve communication skills
* Vision aids, such as glasses or contact lenses, to correct vision problems
* Surgery to correct skeletal abnormalities or other physical complications.

The prognosis for trichothiodystrophy varies depending on the specific form of the disorder and the severity of the symptoms. Some forms of the disorder may have a more favorable prognosis, while others may be associated with significant health problems and a shorter life expectancy. It is important for individuals with trichothiodystrophy to receive prompt and ongoing medical care to manage their symptoms and maximize their quality of life.

Down syndrome can be diagnosed before birth through prenatal testing, such as chorionic villus sampling or amniocentesis, or after birth through a blood test. The symptoms of Down syndrome can vary from person to person, but common physical features include:

* A flat face with a short neck and small ears
* A short stature
* A wide, short hands with short fingers
* A small head
* Almond-shaped eyes that are slanted upward
* A single crease in the palm of the hand

People with Down syndrome may also have cognitive delays and intellectual disability, as well as increased risk of certain medical conditions such as heart defects, gastrointestinal problems, and hearing and vision loss.

There is no cure for Down syndrome, but early intervention and proper medical care can greatly improve the quality of life for individuals with the condition. Treatment may include speech and language therapy, occupational therapy, physical therapy, and special education programs. With appropriate support and resources, people with Down syndrome can lead fulfilling and productive lives.

1. Abdominal obesity (excess fat around the waistline)
2. High blood pressure (hypertension)
3. Elevated fasting glucose (high blood sugar)
4. High serum triglycerides (elevated levels of triglycerides in the blood)
5. Low HDL cholesterol (low levels of "good" cholesterol)

Having three or more of these conditions is considered a diagnosis of metabolic syndrome X. It is estimated that approximately 34% of adults in the United States have this syndrome, and it is more common in women than men. Risk factors for developing metabolic syndrome include obesity, lack of physical activity, poor diet, and a family history of type 2 diabetes or CVD.

The term "metabolic syndrome" was first introduced in the medical literature in the late 1980s, and since then, it has been the subject of extensive research. The exact causes of metabolic syndrome are not yet fully understood, but it is believed to be related to insulin resistance, inflammation, and changes in body fat distribution.

Treatment for metabolic syndrome typically involves lifestyle modifications such as weight loss, regular physical activity, and a healthy diet. Medications such as blood pressure-lowering drugs, cholesterol-lowering drugs, and anti-diabetic medications may also be prescribed if necessary. It is important to note that not everyone with metabolic syndrome will develop type 2 diabetes or CVD, but the risk is increased. Therefore, early detection and treatment are crucial in preventing these complications.

... I (CS-A) manifests in childhood. Cockayne syndrome II (CS-B) manifests at birth or in infancy, and it has a ... Cockayne syndrome type B (CSB), also known as "cerebro-oculo-facio-skeletal (COFS) syndrome" (or "Pena-Shokeir syndrome type B ... The prognosis for Cockayne syndrome varies by disease type. There are three types of Cockayne syndrome according to the ... No racial predilection is reported for Cockayne syndrome. No sexual predilection is described for Cockayne syndrome; the male- ...
Werner syndrome (WS) Bloom syndrome (BS) Rothmund-Thomson syndrome (RTS) Cockayne syndrome (CS) Xeroderma pigmentosum (XP) ... Examples of PS include Werner syndrome (WS), Bloom syndrome (BS), Rothmund-Thomson syndrome (RTS), Cockayne syndrome (CS), ... "Cockayne syndrome". Genetics Home Reference. NIH. Retrieved 19 March 2013. Nance, MA; Berry, SA (1992). "Cockayne syndrome: ... Some segmental progeroid syndromes, such as Werner syndrome (WS), Bloom syndrome (BS), Rothmund-Thomson syndromes (RTS) and ...
1995). "The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA ... 2002). "Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled ... This gene encodes a WD repeat protein, which interacts with the Cockayne syndrome type B (CSB) and p44 proteins, the latter ... Cao H, Williams C, Carter M, Hegele RA (2004). "CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common ...
Weber-Cockayne syndrome: A form of epidermolysis bullosa. Named with Edward Alfred Cockayne. Parkes Weber syndrome: A rare ... His name is ascribed to several disorders such as: Klippel-Trénaunay-Weber syndrome: A rare syndrome characterized by enlarged ... Sturge-Weber syndrome: A congenital disorder involving the brain, skin and eyes. In 1922, Weber reported the first radiologic ... Thomas-Sohl, Kristin A; Vaslow, Dale F; Maria, Bernard L (May 2004). "Sturge-Weber syndrome: A review". Pediatric Neurology. 30 ...
Members 6 and 8 are associated with Cockayne syndrome. Wolfram Siede; Friedberg, Errol C.; Walker, Graham S. (1995). "Chapter 8 ...
Talwar D, Smith SA (October 1989). "CAMFAK syndrome: a demyelinating inherited disease similar to Cockayne syndrome". Am. J. ... CAMFAK syndrome (or CAMAK syndrome) is an acronym used to describe a rare inherited neurologic disease, characterized by ... similar to that seen in Cockayne syndrome. The name "CAMFAK" comes from the first letters of the characteristic findings of the ... A demyelinating inherited disease similar to Cockayne syndrome". American Journal of Medical Genetics. 34 (2): 194-198. doi: ...
Cockayne syndrome II, or Severe Cockayne Syndrome: in which facial and somatic abnormalities are present at birth. Death ... Additional information on Cockayne's Syndrome (PDF) Edward Alfred Cockayne @ Who Named It NHM Cockayne Lepidoptera collection ... This disease has since been divided into three subtypes: Cockayne syndrome I, or Classic Cockayne Syndrome: in which facial and ... Cockayne syndrome III: milder than Cockayne I & II, and its onset happens later than the other two types. In 1933 he published ...
Yu A, Fan HY, Liao D, Bailey AD, Weiner AM (May 2000). "Activation of p53 or loss of the Cockayne syndrome group B repair ... In humans, Cockayne syndrome (CS) is a rare autosomal recessive leukodystrophy (associated with the degradation of white matter ... Dianov G, Bischoff C, Sunesen M, Bohr VA (Mar 1999). "Repair of 8-oxoguanine in DNA is deficient in Cockayne syndrome group B ... Fryns JP, Bulcke J, Verdu P, Carton H, Kleczkowska A, Van den Berghe H (Sep 1991). "Apparent late-onset Cockayne syndrome and ...
... or a combination of XP and Cockayne syndrome (XPCS). Both trichothiodystrophy and Cockayne syndrome display features of ... DeSanctis-Cacchione syndrome Genetic disorder Biogerontology Cockayne syndrome List of cutaneous conditions List of cutaneous ... or in combination with Cockayne syndrome (CS), or in combination with infantile lethal cerebro-oculo-facio-skeletal syndrome. ... Mutations in the XPB(ERCC3) gene can lead to XP or XP combined with Cockayne syndrome. The XPC protein forms a complex with ...
Xeroderma pigmentosum and Cockayne's syndrome are two examples of NER associated diseases. Nucleotide excision repair is more ... Iyama T, Wilson DM (2016). "Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome". J. Mol ... Koch S, Garcia Gonzalez O, Assfalg R, Schelling A, Schäfer P, Scharffetter-Kochanek K, Iben S (2014). "Cockayne syndrome ... Cockayne syndrome (CS) arises from germline mutations in either of two genes ERCC8(CSA) or ERCC6(CSB). ERCC8(CSA) mutations ...
Cockayne syndrome results from a mutation in genes that interfere with transcription-coupled repair of nuclear and ... "Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration". Mechanisms of ... Disconnection syndromes, defined as any neurologic disorder caused by an interruption in impulse transmission along cerebral ... disconnection syndromes, respiratory chain deficient neuron interaction, and lobectomies. Although there are different causes, ...
... and Cockayne syndrome (mean lifespan 13 years). Werner syndrome is due to an inherited defect in an enzyme (a helicase and ... Bloom syndrome and Rothmund-Thomson syndrome. In addition to human inherited syndromes, experimental mouse models with genetic ... Cockayne Syndrome is due to a defect in a protein necessary for the repair process, transcription coupled nucleotide excision ... Iyama T, Wilson DM (2016). "Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome". J. Mol ...
Ataxia-telangiectasia Bloom syndrome Cockayne syndrome Fanconi anemia Progeria (Hutchinson-Gilford progeria syndrome) Rothmund- ... Iyama T, Wilson DM (2016). "Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome". J. Mol ... Cockayne Syndrome and trichothiodystrophy show mainly features of accelerated aging, but apparently without an increased risk ... Thomson syndrome Trichothiodystrophy Werner syndrome Xeroderma pigmentosum Some examples of DNA repair defects causing ...
Most XP-F patients show moderate symptoms of XP, but a few show additional symptoms of Cockayne syndrome. Cockayne syndrome (CS ... When the normal genes are absent, these mutations can lead to human syndromes, including xeroderma pigmentosum, Cockayne ... "Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma ... Mutations in the ERCC4 gene can result in the very rare XF-E syndrome. These patients have characteristics of XP and CS, as ...
Mutations cause Cockayne syndrome, which is characterized by severe growth defects, mental retardation, and cachexia. Multiple ... Cockayne syndrome))". Drury S, Boustred C, Tekman M, Stanescu H, Kleta R, Lench N, Chitty LS, Scott RH (July 2014). "A novel ... Cockayne syndrome, and trichothiodystrophy". Human Mutation. 14 (1): 9-22. doi:10.1002/(SICI)1098-1004(1999)14:1. 3.0.CO;2-6. ... and Cockayne syndrome group B (CSB) protein". Biochemistry. 35 (7): 2157-67. doi:10.1021/bi9524124. PMID 8652557. Park MS, ...
Mutations in the XPB(ERCC3) gene can lead, in humans, to xeroderma pigmentosum (XP) or XP combined with Cockayne syndrome (XPCS ... Scott RJ, Itin P, Kleijer WJ, Kolb K, Arlett C, Muller H (1993). "Xeroderma pigmentosum-Cockayne syndrome complex in two ... and Cockayne syndrome group B (CSB) protein". Biochemistry. 35 (7): 2157-67. doi:10.1021/bi9524124. PMID 8652557. Wang XW, Yeh ... Cockayne syndrome, and trichothiodystrophy". Hum. Mutat. 14 (1): 9-22. doi:10.1002/(SICI)1098-1004(1999)14:1. 3.0.CO;2-6. PMID ...
There are multiple components involved in the NER pathway, including Xeroderma pigmentosum (XP) A-G and V, Cockayne syndrome ( ... Cockayne syndrome, and trichothiodystrophy". Hum. Mutat. 14 (1): 9-22. doi:10.1002/(SICI)1098-1004(1999)14:1. 3.0.CO;2-6. PMID ...
Cockayne syndrome, and trichothiodystrophy". Human Mutation. 14 (1): 9-22. doi:10.1002/(SICI)1098-1004(1999)14:1. 3.0.CO;2-6. ... syndrome and Fanconi anemia group C in a 2.6-cM interval and contributes to the fine map of 9q22.3". Genomics. 23 (2): 486-9. ...
... and Cockayne syndrome. Just like XPB, XPD is a part of human transcriptional initiation factor TFIIH and has ATP-dependent ... and Cockayne syndrome group B (CSB) protein". Biochemistry. 35 (7): 2157-67. doi:10.1021/bi9524124. PMID 8652557. Drapkin R, ... Cockayne syndrome, and trichothiodystrophy". Human Mutation. 14 (1): 9-22. doi:10.1002/(SICI)1098-1004(1999)14:1. 3.0.CO;2-6. ... or a combination of XP and Cockayne syndrome (XPCS). TTD and CS both display features of premature aging. These features may ...
However without this repair, conditions such as UV-sensitive syndrome, xeroderma pigmentosum, and Cockayne syndrome may arise. ... Mutations in these genes cause Cockayne Syndrome, which is characterized by early cessation of growth and development, leading ... This condition can occur alongside xeroderma pigmentosum, resulting in xeroderma pigmentosum-cockayne syndrome (XP-CS). OGG1 ... The least severe of the three, people suffering from UV-sensitive syndrome experience UV-hypersensitivity. The syndrome arises ...
... or XP combined with Cockayne syndrome. In addition to genetic variations, virus-encoded proteins also target TFIIH. TFIIH ... xeroderma pigmentosum without and with Cockayne syndrome". Human Mutation. 27 (11): 1092-103. doi:10.1002/humu.20392. PMID ...
Solar urticaria List of cutaneous conditions Cockayne syndrome Xeroderma pigmentosum Nucleotide excision repair Rapini, Ronald ... "UV sensitive syndrome , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". rarediseases.info.nih.gov. ... UV-sensitive syndrome is a cutaneous condition inherited in an autosomal recessive fashion, characterized by photosensitivity ... Recent research identified that mutations of the KIAA1530 (UVSSA) gene as cause for the development of UV-sensitive syndrome. ...
The Cockayne Syndrome B protein (CSB) (coded for by ERCC6) localizes at double-strand breaks at sites of active transcription, ... Cockayne syndrome B-dependent homologous recombination". Proc. Natl. Acad. Sci. U.S.A. 112 (27): E3495-504. doi:10.1073/pnas. ...
"Impaired Genome Maintenance Suppresses the Growth Hormone-Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome". ... progeroid syndromes and cellular senescence Niedernhofer studied from 1981 to 1985 at Duke University graduating with a B.S. ... "A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis". Nature. 444 (7122): 1038-1043. Bibcode ... "First Reported Patient with Human ERCC1 Deficiency Has Cerebro-Oculo-Facio-Skeletal Syndrome with a Mild Defect in Nucleotide ...
These type of defects can result in other rare autosomal recessive diseases like xeroderma pigmentosum and Cockayne syndrome. ... BIDS syndrome, also called Amish brittle hair brain syndrome and hair-brain syndrome, is an autosomal recessive inherited ... is the Tay syndrome or sulfur-deficient brittle hair syndrome, first described by Tay in 1971. (Chong Hai Tay was the ... 501 There is a photosensitive syndrome, PBIDS. BIDS is associated with the gene MPLKIP (TTDN1). IBIDS syndrome, following the ...
Cockayne syndrome, trichothiodystrophy). He found with Jean-Marc Egly that Transcription Factor II H (TFIIH) opens the DNA for ...
... exonuclease that forms a complex with the Cockayne syndrome B (CSB) protein. In this complex, CSB modulates the exonuclease ... carry out its repair function may contribute to the degenerative pathologies and premature aging features of Cockayne syndrome ...
"Bloom syndrome". Genetics Home Reference. Retrieved 2020-04-11. "OMIM Entry - # 216400 - COCKAYNE SYNDROME A; CSA". omim.org. ... Cockayne syndrome is a homozygous or heterozygous mutation that results in short stature, abnormalities in head size, and slow ... Progeroid syndromes are genetic diseases that are linked to premature aging. Progeroid syndromes are characterized by having ... Werner syndrome, also known as "adult progeria", is another single-gene genetic disease. it is caused by a mutation in the wrn ...
"Identical mutations in the CSB gene associated with either Cockayne syndrome or the de Sanctis-Cacchione variant of xeroderma ... Rare syndromes, Syndromes affecting the skin, Syndromes affecting the eye, Syndromes affecting head size, Syndromes with ... "Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma ... DeSanctis-Cacchione syndrome or Xeroderma pigmentosum is a genetic disorder characterized by the skin and eye symptoms of ...
When the normal genes are absent, these mutations can lead to human syndromes, including Cockayne syndrome (CS) and COFS. ERCC1 ... One Cockayne syndrome (CS) type II patient designated CS20LO exhibited a homozygous mutation in exon 7 of ERCC1, producing a ... May 2013). "Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, ... COFS syndrome is a rare recessive disorder in which affected individuals undergo rapid neurologic decline and indications of ...
Jewish Disorder Cockayne syndrome type 1 Cockayne syndrome type 2 Cockayne syndrome type 3 Cockayne's syndrome Codas syndrome ... CCA syndrome Ccge syndrome CCHS CDG syndrome CDG syndrome type 1A CDG syndrome type 1B CDG syndrome type 1C CDG syndrome type 2 ... syndrome Coffin-Siris syndrome COFS syndrome Cogan-Reese syndrome Cogan syndrome Cohen-Gibson syndrome Cohen-Hayden syndrome ... articular syndrome Chudley-Lowry-Hoar syndrome Chudley-Rozdilsky syndrome Chudley-Mccullough syndrome Churg-Strauss syndrome ...
... and Cockayne syndrome group B (CSB) protein". Biochemistry. 35 (7): 2157-67. doi:10.1021/bi9524124. PMID 8652557. Vadlamudi RK ...
Patients and Families affected by Xeroderma Pigmentosum and Cockayne Syndrome Carol Mary Matthews, Chief Executive, The ... For services to People with Post Intensive Care Syndrome. Jasvir Kaur Rababan. For services to the Sikh community. Mohammed ...
... resulting in increased skin cancer incidence and premature aging Cockayne syndrome: hypersensitivity to UV and chemical agents ... Other DNA repair disorders include: Werner's syndrome: premature aging and retarded growth Bloom's syndrome: sunlight ... Humans born with inherited defects in DNA repair mechanisms (for example, Li-Fraumeni syndrome) have a higher cancer risk. The ... German J (March 1969). "Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients". American ...
... syndrome Cockayne syndrome Colobomas of the eye-heart defects-ichthyosiform dermatosis-mental retardation-ear defects syndrome ... Turner syndrome Ulnar-mammary syndrome Van Der Woude syndrome Von Hippel-Lindau syndrome Watson syndrome Werner syndrome (adult ... Freeman-Sheldon syndrome, Windmill-Vane-Hand syndrome) Wilson-Turner syndrome Wolf-Hirschhorn syndrome (4p- syndrome) X-linked ... Rombo syndrome Rothmund-Thomson syndrome (poikiloderma congenitale) Rud syndrome Say syndrome Scalp-ear-nipple syndrome (Finlay ...
Caesarean section, a surgical procedure to deliver one or more babies, or, rarely, to remove a dead fetus Cockayne syndrome, a ... and their synthetic analogues Cowden syndrome, a rare autosomal dominant inherited disorder (-)-camphene synthase, an enzyme CS ...
... lissencephaly with abnormal genitalia Aicardi-Goutières syndrome Ataxia telangiectasia Cohen syndrome Cockayne syndrome ... Syndromes Chromosomal Poland syndrome Down syndrome Edward syndrome Patau syndrome Unbalanced rearrangements Contiguous gene ... Williams syndrome) 22q11 deletion (DiGeorge syndrome) Single gene defects Smith-Lemli-Opitz syndrome Seckel syndrome Cornelia ... Miller-Dieker syndrome) Single gene defects Rett syndrome (primarily girls) Nijmegen breakage syndrome X-linked ...
RPGRIP1L COACH syndrome; 216360; TMEM67 Cockayne syndrome type A; 216400; ERCC8 Cockayne syndrome type B; 133540; ERCC6 Cocoon ... AKAP9 Long QT syndrome-3; 603830; SCN5A Long QT syndrome-4; 600919; ANK2 Long QT syndrome-7; 170390; KCNJ2 Long QT syndrome-9; ... TGFBR2 Long QT syndrome 12; 612955; SNT1 Long QT syndrome 13; 613485; KCNJ5 Long QT syndrome-1; 192500; KCNQ1 Long QT syndrome- ... KRAS Noonan syndrome 4; 610733; SOS1 Noonan syndrome 5; 611553; RAF1 Noonan syndrome 6; 613224; NRAS Noonan-like syndrome with ...
November 1993). "Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton ... October 2006). "Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal ...
... cockayne syndrome MeSH C05.116.099.343.347 - congenital hypothyroidism MeSH C05.116.099.343.445 - dwarfism, pituitary MeSH ... Klippel-Feil syndrome MeSH C05.116.099.370.652 - orofaciodigital syndromes MeSH C05.116.099.370.797 - Rubinstein-Taybi syndrome ... Hajdu-Cheney syndrome MeSH C05.116.099.105 - basal-cell nevus syndrome MeSH C05.116.099.343 - dwarfism MeSH C05.116.099.343.110 ... Felty's syndrome MeSH C05.550.114.154.683 - rheumatoid nodule MeSH C05.550.114.154.774 - Sjögren syndrome MeSH C05.550.114.154. ...
Epidyolex was approved for the adjunctive therapy of seizures associated with Lennox-Gastaut syndrome or with Dravet syndrome ... Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, et al. (September 2003). "Activation of CB2 cannabinoid receptors ... Lennox-Gastaut syndrome and Dravet syndrome, and seizures associated with tuberous sclerosis complex. In the US, it is approved ... is indicated for use as adjunctive therapy of seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome (DS), ...
English classical composer Edward Elgar completed writing the Cockaigne Overture. La Nación, a newspaper in Buenos Aires, ... became the first scientist to identify the Hallermann-Streiff syndrome, in Arnsberg, Germany (d. 1975) Died: Sam Browne, 76, ...
"COCKAYNE, Edward Alfred (1880-1956)". Royal College of Physicians. Retrieved 25 August 2010. "Obituary Notices". BMJ. 3 (5819 ... a new endocrine syndrome 1975 Ronald W. Raven, Oncology : attainment and anticipation 1974 Richard S. Handley, Carcinoma of the ... The cause and prognosis of the nephrotic syndrome 1966 David W. Smithers, Hodgkin's Disease 1965 Douglas Andrew Kilgour Black, ... Chemotherapy of Bacterial Infections 1937 Edward Alfred Cockayne, Genetics of Transposition of the Viscera 1936 Edward Mapother ...
CLOVES syndrome COACH syndrome Cobb syndrome Cockayne syndrome Coffin-Lowry syndrome Coffin-Siris syndrome Cogan syndrome Cohen ... syndrome Wende-Bauckus syndrome Werner syndrome Wernicke-Korsakoff syndrome West syndrome Westerhof syndrome Wet lung syndrome ... syndrome Shone's syndrome Short anagen syndrome Short bowel syndrome short limb syndrome Short man syndrome Short QT syndrome ... syndrome Radial tunnel syndrome Rage syndrome Raghib syndrome Raine syndrome Ramos-Arroyo syndrome Ramsay Hunt syndrome type 1 ...
... syndrome Edwards-Patton-Dilly syndrome Edwards syndrome Eec syndrome without cleft lip palate Eec syndrome Eem syndrome Egg ... Cockayne-Touraine type Epidermolysis bullosa simplex, Koebner type Epidermolysis bullosa simplex, Ogna type Epidermolysis ... Egg shaped pupils Ehlers-Danlos syndrome Ehrlichiosis Eijkman's syndrome Eiken syndrome Eisenmenger syndrome Ekbom syndrome ... Elliott-Ludman-Teebi syndrome Ellis-Yale-Winter syndrome Ellis-van Creveld syndrome Emerinopathy Emery-Nelson syndrome Emery- ...
... headache Cockayne syndrome Coffin-Lowry syndrome Coma Complex post-traumatic stress disorder Complex regional pain syndrome ... 15 Joubert syndrome Karak syndrome Kearns-Sayre syndrome Kinsbourne syndrome Kleine-Levin syndrome Klippel Feil syndrome Krabbe ... Febrile seizures Fisher syndrome Fibromyalgia Foville's syndrome Fragile X syndrome Fragile X-associated tremor/ataxia syndrome ... syndrome Shingles Shy-Drager syndrome Sjögren's syndrome Sleep apnea Sleeping sickness Slurred speech Snatiation Sotos syndrome ...
Apert syndrome Barakat syndrome Beare-Stevenson cutis gyrata syndrome Charcot-Marie-Tooth disease Cockayne syndrome Congenital ... syndrome Genitopatellar syndrome Glioblastoma multiforme Hermansky-Pudlak syndrome Hirschprung disease Jackson-Weiss syndrome ... Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) FRA10AC1: Fragile site, folic acid type FRAT1: WNT signaling ... type Tetrahydrobiopterin deficiency Thiel-Behnke corneal dystrophy Usher syndrome Wolman syndrome Young-Simpson syndrome G- ...
... type 4 Cockayne syndrome Cornelia de Lange syndrome Corneal dystrophy of Bowman layer Cri du chat Diastrophic dysplasia Ehlers- ... Syndrome Survival motor neuron spinal muscular atrophy Treacher Collins syndrome Tricho-hepato-enteric syndrome Usher syndrome ... Chromosome 5q deletion syndrome is caused by the deletion of the q arm (long arm) of chromosome 5. This deletion has been ... AB variant Homocystinuria 3-Methylcrotonyl-CoA carboxylase deficiency Myelodysplastic syndrome Netherton syndrome Nicotine ...
Five of them (xeroderma pigmentosum, Cockayne's syndrome, trichothiodystrophy, Down's syndrome, and triple-A syndrome) have a ... German, J (Mar 1969). "Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients". Am J Hum ... Rare fragile sites can lead to genetic disease such as fragile X mental retardation syndrome, myotonic dystrophy, Friedrich's ... Four (ataxia-telangiectasia, ataxia-telangiectasia-like disorder, Nijmegen breakage syndrome and Alzheimer's disease) are ...
Find symptoms and other information about Cockayne syndrome. ... Share and Care Cockayne Syndrome Network Inc.. People With. ... Cockayne syndrome is caused by genetic changes in either the ERCC8 (CSA) or ERCC6 (CSB) genes. Inheritance is autosomal ... When Do Symptoms of Cockayne syndrome Begin?. Symptoms of this disease may start to appear at any time in life.. The age ... About Cockayne syndrome. Many rare diseases have limited information. Currently GARD aims to provide the following information ...
Cockayne syndrome is a rare disorder characterized by an abnormally small head size (microcephaly), short stature, and delayed ... medlineplus.gov/genetics/condition/cockayne-syndrome/ Cockayne syndrome. ... Cockayne syndrome type II is also known as cerebro-oculo-facio-skeletal (COFS) syndrome, and while some researchers consider it ... Cockayne syndrome can result from mutations in either the ERCC6 gene (also known as CSB) or the ERCC8 gene (also known as CSA ...
... syndrome, Pena-Shokeir type 2 syndrome); Cockayne syndrome type 3, a milder form; and xeroderma pigmentosa-Cockayne syndrome ( ... spans a spectrum that includes Cockayne syndrome type 1, the classic form; Cockayne syndrome type 2, a more severe form with ... encoded search term (Genetics of Cockayne Syndrome) and Genetics of Cockayne Syndrome What to Read Next on Medscape ... Genetics of Cockayne Syndrome Medication. Updated: Dec 02, 2019 * Author: Reem Saadeh-Haddad, MD; Chief Editor: Maria Descartes ...
Cockayne syndrome is a rare disorder characterized by an abnormally small head size (microcephaly), short stature, and delayed ... medlineplus.gov/genetics/condition/cockayne-syndrome/ Cockayne syndrome. ... Cockayne syndrome type II is also known as cerebro-oculo-facio-skeletal (COFS) syndrome, and while some researchers consider it ... Cockayne syndrome can result from mutations in either the ERCC6 gene (also known as CSB) or the ERCC8 gene (also known as CSA ...
Cockayne syndrome is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% ... Clinical characteristics: Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that ... Genetic counseling: Cockayne syndrome is inherited in an autosomal recessive manner. At conception, each sib of an affected ... Diagnosis/testing: The diagnosis of Cockayne syndrome is established in a proband with the identification of biallelic ...
Cockayne Syndrome. A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; ... Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the ... All MeSH CategoriesDiseases CategoryMusculoskeletal DiseasesBone DiseasesBone Diseases, DevelopmentalDwarfismCockayne Syndrome ... MultipleCockayne Syndrome. All MeSH CategoriesDiseases CategoryCongenital, Hereditary, and Neonatal Diseases and Abnormalities ...
Cockayne syndrome group B protein prevents mitochondrial stress and promotes autophagy ...
Cockayne syndrome B (CSB), best known for its role in transcription-coupled nucleotide excision repair (TC-NER), contains a ... Cockayne syndrome group B (CSB) protein: at the crossroads of transcriptional networks. Vélez-Cruz R, Egly JM. Vélez-Cruz R, et ... Role of Cockayne Syndrome Group B Protein in Replication Stress: Implications for Cancer Therapy. Walker JR, Zhu XD. Walker JR ... Cockayne syndrome B (CSB), best known for its role in transcription-coupled nucleotide excision repair (TC-NER), contains a ...
Batra P, Saha A, Kumar A. Infantile onset of Cockayne syndrome in two siblings. Indian Journal of Dermatology, Venereology and ...
Cockayne Syndrome. Metronidazole Tablets are contraindicated in patients with Cockayne syndrome. Severe irreversible ... have been reported in patients with Cockayne syndrome (latency from drug start to signs of liver failure as short as 2 days) ( ... liver failure with fatal outcomes have been reported after initiation of metronidazole in patients with Cockayne syndrome (see ... Hypersensitivity: Urticaria, erythematous rash, Stevens-Johnson Syndrome, toxic epidermal necrolysis, flushing, nasal ...
Cockayne syndrome (CS) is a rare autosomal recessive disorder common in Christian Arabs due to a p.Tyr322X mutation. Genetic ... High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome ... Árabes/genética Síndrome de Cockayne/genética Enzimas Reparadoras do DNA/genética Mutação Fatores de Transcrição/genética ...
Cockayne syndrome and xeroderma pigmentosum. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH. Cockayne syndrome and ...
Weber-Cockayne syndrome; Epidermolysis bullosa simplex ...
Cockayne syndrome ... a serious reaction to an antibiotic medication called metronidazole. If affected individuals take this ... Metronidazole Toxicity in Cockayne Syndrome: A Case Series. Pediatrics. ... ...
Cockayne Syndrome (CS) is a rare autosomal recessive disorder characterized by neurological and sensorial impairment, dwarfism ... From: First molecular study in Lebanese patients with Cockayne syndrome and report of a novel mutation in ERCC8 gene ...
Boltshauser E, Yalcinkaya C, Wichmann W, Reutter F, Prader A, Valavanis A. MRI in Cockayne syndrome type I. Neuroradiology. ... Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD ... Cockayne Syndrome, or Trichothiodystrophy. This study is currently recruiting participants. ... that are first degree relatives or other family members of participants with XP, CS, TTD, or overlap syndromes -Healthy ...
Werners syndrome, Blooms syndrome, Downs syndrome, and Cockaynes syndrome. * Genes responsible for recessive conditions ... Genes which are relevant to progeroid syndromes in which several age-related changes are accelerated, e.g. ...
... formerly Rett syndrome), as well as more recently described c … ... Among these are classic disorders such as Angelman syndrome and ... Pitt-Hopkins syndrome; Rubinstein-Taybi syndrome; Warburg MICRO syndrome, Cockayne syndrome, Cerebral-oculo-facial skeletal ... A second diagnostic grouping, comprised of Warburg MICRO syndrome, Cockayne syndrome, and Cerebral-oculo-facial skeletal ... Rubinstein-Taybi syndrome), FOXG1, SLC9A6 (Christianson syndrome), and TCF4 (Pitt-Hopkins syndrome). These disorders can be ...
MeSH Terms: Cells, Cultured; Child; Cockayne Syndrome/diagnosis; Cockayne Syndrome/genetics*; DNA Helicases/genetics*; DNA ... Abstract: BACKGROUND: Cockayne syndrome (CS) is a rare autosomal recessive disorder characterized by growth failure and ... Title: Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndrome. ...
Neurologic and other skin findings are also part of the related disorders trichothiodystrophy and Cockayne syndrome. [105] ... Predisposing genetic conditions are associated with ALL, including Down syndrome, Bloom syndrome, Wiskott-Aldrich syndrome, ... 93] In contrast, outcomes tend to be better in AML in children with Down syndrome than in children without Down syndrome. ... 113] DiGeorge syndrome is part of the family of 22q11.2 deletion syndromes, and is characterized by immunodeficiency, ...
... but relies on RAD52 and Cockayne Syndrome Protein B (CSB). During TC-HR, RAD52 is recruited by CSB through an acidic domain. ... The ATPase domain but not the acidic region of Cockayne Syndrome Group B gene product is essential for DNA repair. Mol. Biol. ... The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genet ... DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination. Proc. Natl ...
The study sheds light on the mechanistic basis of a rare genetic condition known as Cockayne syndrome neurologic disease. A ... How the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic ... PJ Brooks of the Division of Metabolism and Health Effects spoke with Marina Hutchinson of the Associated Press about Cockayne ... of which fetal alcohol syndrome (FAS) is the most severe. Yet up to 30 percent of women report drinking alcohol during ...
a certain rare genetic disorder (Cockayne syndrome). This product may cause live bacterial vaccines (such as typhoid vaccine) ...
... is a neurodegenerative syndrome characterized by prominent cerebellar and extrapyramidal signs, dysarthria, and dysphagia. ... Gene map locus 10q11; an excision repair gene named variously ERCC6, CKN2, COFS, and CSB causing Cockayne syndrome type B (CSB ... Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma ... overlaps with known types of xeroderma pigmentosum and Cockayne syndrome, especially XPA and CSB, apparently as allelic ...
Insights into xeroderma pigmentosum, Cockaynes syndrome and trichothiodystrophy. Mutat Res273(2):97-118 1992. ... in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. ...
DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination.. Proc. Natl. ... DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination.. Proc. Natl. ... DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination.. Proc. Natl. ... DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination. ...
Type A Cockayne Syndrome Type B Cockayne Syndrome Type C Cockayne Syndrome Type I Cockayne Syndrome Type II Cockayne Syndrome ... Cockayne Syndrome, Type A Cockayne Syndrome, Type B Cockayne Syndrome, Type C Cockayne Syndrome, Type I Cockayne Syndrome, Type ... Cockayne Syndrome Type 3 Cockayne Syndrome Type C Cockayne Syndrome, Group A Cockayne Syndrome, Group B Cockayne Syndrome, ... Group A Cockayne Syndrome Group B Cockayne Syndrome Group C Cockayne Syndrome Progeria-Like Syndrome Progeroid Nanism ...
The role of Cockayne Syndrome group B (CSB) in repeat expansion in Fragile X premutation mice. Tuesday, October 25, 2011 - ... we have crossed Fragile X premutation knock-in mice to mice with mutations in Cockayne syndrome group B (CSB), an important ... One member of this group of diseases is Fragile X syndrome (FXS), the most common cause of inherited intellectual disability. ...
  • Many premature aging syndromes are due to defective DNA repair systems. (prolekarniky.cz)
  • Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. (nih.gov)
  • Phenotypic variability in xeroderma pigmentosum group G: An uncommon case with severe prenatal-onset Cockayne syndrome features. (nih.gov)
  • The endonuclease XPG is involved in repair of helix-distorting DNA lesions, and XPG defects cause the cancer-prone condition xeroderma pigmentosum (XP) alone or combined with the severe neurodevelopmental progeroid disorder Cockayne syndrome (CS). (prolekarniky.cz)
  • Cockayne syndrome is caused by genetic changes in either the ERCC8 (CSA) or ERCC6 (CSB) genes. (nih.gov)
  • Cockayne syndrome can result from mutations in either the ERCC6 gene (also known as CSB ) or the ERCC8 gene (also known as CSA ). (medlineplus.gov)
  • High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome among Christian Arabs in Northern Israel. (bvsalud.org)
  • ERCC8 is a WD repeat protein, which interacts with Cockayne syndrome type B (CSB) protein and with p44 protein, a subunit of the RNA polymerase II transcription factor IIH. (prosci-inc.com)
  • To understand the relationship between TCR and expansion, we have crossed Fragile X premutation knock-in mice to mice with mutations in Cockayne syndrome group B (CSB), an important gene in the TCR pathway. (nih.gov)
  • Mutations in this gene have been identified in patients with hereditary disease Cockayne syndrome (CS). (prosci-inc.com)
  • Cockayne syndrome (CS) is a rare inherited human genetic disorder characterized by UV sensitivity, developmental abnormalities and premature aging. (hacettepe.edu.tr)
  • Cockayne syndrome is a rare disease which causes short stature, premature aging (progeria), severe photosensitivity, and moderate to severe learning delay. (nih.gov)
  • Ending a diagnostic odyssey: Moving from exome to genome to identify cockayne syndrome. (nih.gov)
  • My last major post traced developments related to a form of progeria (premature aging) known as Hutchinson-Gilford progeria syndrome , or HGPS , for short. (anti-agingfirewalls.com)
  • There is also a different rare form of progeria known as Werner Syndrome (WS) that is worth looking at for what it might tell us about normal aging. (anti-agingfirewalls.com)
  • Weidenheim KM, Dickson DW, Rapin I. Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration. (medlineplus.gov)
  • When Do Symptoms of Cockayne syndrome Begin? (nih.gov)
  • Cockayne syndrome is sometimes divided into types I, II, and III based on the severity and age of onset of symptoms. (medlineplus.gov)
  • If medical professionals did not diagnose or treat your cauda equina syndrome symptoms in time, you can claim for compensation. (thompsons.law)
  • In fact, some of the genes known to be mutated in these syndromes can be mutated in patients with isolated RP. (mhmedical.com)
  • Cockayne syndrome is a rare disorder characterized by an abnormally small head size (microcephaly), a failure to gain weight and grow at the expected rate (failure to thrive) leading to very short stature, and delayed development. (medlineplus.gov)
  • Cockayne syndrome (CS) is a rare autosomal recessive disorder common in Christian Arabs due to a p.Tyr322X mutation . (bvsalud.org)
  • BACKGROUND: Cockayne syndrome (CS) is a rare autosomal recessive disorder characterized by growth failure and multisystemic degeneration. (nih.gov)
  • People with Cockayne syndrome have a serious reaction to an antibiotic medication called metronidazole. (medlineplus.gov)
  • Some researchers highlight the roles of cell senescence and telomeres in WS: "Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts( ref ). (anti-agingfirewalls.com)
  • Cockayne syndrome type II is also known as cerebro-oculo-facio-skeletal (COFS) syndrome, and while some researchers consider it to be a separate but similar condition, others classify it as part of the Cockayne syndrome disease spectrum. (medlineplus.gov)
  • Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. (medlineplus.gov)
  • The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. (medlineplus.gov)
  • Intervention to correct mitochon reporting system to alert the leadership to organizational shortcomings that compro drial function in Cockayne Syndrome of the NIH Clinical Center about a variety mise patient safety. (nih.gov)
  • This work was focused on molecular genetics, disease gene cloning, and genetic diagnosis of several rare disorders of the central nervous system (CNS), including Canavan disease, Hurler syndrome, and Hunter syndrome. (umassmed.edu)
  • However, the localization of RAD51 to damage sites during TC-HR does not require BRCA1 and BRCA2, but relies on RAD52 and Cockayne Syndrome Protein B (CSB). (nature.com)
  • Cockayne syndrome is estimated to occur in 2 to 3 per million newborns in the United States and Europe. (medlineplus.gov)
  • In some cases, cauda equina syndrome can also occur as a result of surgical errors. (thompsons.law)
  • The faulty DNA repair underlies photosensitivity in affected individuals, and researchers suspect that it also contributes to the other features of Cockayne syndrome. (medlineplus.gov)
  • An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). (lookformedical.com)
  • His diagnosis and treatment of cauda equina syndrome was delayed , resulting in life-long injuries including impaired mobility, numbness in his saddle area, genitals, and down the back of his legs, pain in his left leg, sexual dysfunction, and bladder and bowel dysfunction. (thompsons.law)
  • Her concerns about numbness in her feet were ignored and a diagnosis of cauda equina syndrome was delayed. (thompsons.law)
  • One member of this group of diseases is Fragile X syndrome (FXS), the most common cause of inherited intellectual disability. (nih.gov)
  • This could happen if you have Cockayne Syndrome, Bloom Syndrome, Albinism, Systemic Lupus Erythematosus, or a similar condition. (micdot.com)
  • You can make a cauda equina syndrome claim if your condition has been caused or worsened by poor medical treatment. (thompsons.law)
  • This syndrome also includes failure to thrive, very small head (microcephaly), and impaired nervous system development. (nih.gov)
  • However, in people with Cockayne syndrome, DNA damage is not repaired normally. (medlineplus.gov)
  • Our solicitors have extensive experience of supporting people suffering from cauda equina syndrome resulting from medical negligence. (thompsons.law)
  • It is essential that cauda equina syndrome is diagnosed and treated as soon as possible. (thompsons.law)